New donor leukocyte approaches may improve outcomes in relapsed CML post-transplant.
D016026:Bone Marrow Transplantation; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D017708:Leukocyte Transfusion; D012008:Recurrence; D016896:Treatment Outcome